WillItSurvive
Medical technology and health companies · subsidiary of Commure · United States

Memora Health

Care journey messaging platform for hospitals, now absorbed into Commure after a 2024 sale.

Little protection left
Assessed 22 July 2026 · Evidence as of 22 July 2026
Not much stands between this business and its pressures.
On the recordSince 22 July 2026 · Checkable from by 2027 · Every call on the record Checkpoint: Decision on whether Memora survives as a distinct product inside CommureOS or gets fully absorbed
The call

Memora no longer operates as an independent company; its fate now rides entirely on how Commure chooses to use or absorb it.

Memora Health built software to help patients handle routine health questions through text messages and AI, instead of calling their doctor's office. The company claimed its strength was deep connections to hospital computer systems and medical content that doctors trust, but that turned out not to be enough to keep the company going on its own. Epic, the giant that makes the main hospital computer systems, can now build the same patient messaging features directly into their software, and general AI chatbots can do much of what Memora did. The real question now is whether Commure, the company that bought Memora, will keep it as its own product or fold it into their bigger system, which could change what Memora becomes.

Why
01
AI pressure: Generalized LLM/agentic AI (e.g., OpenAI-based triage bots). Generic AI agents can now handle SMS triage and FAQ routing, the exact task Memora built its product to automate. Could AI do the core job? Yes, likely.
02
Bigger players: Epic. Epic bundles patient engagement and messaging directly into its EHR, cutting the need for a separate vendor like Memora. Could a giant copy it? Yes, easily.
03
What protects it. Existing integrations inside hospital systems that already run on Memora's messaging workflows create switching friction.
What would change this call
Commure announces CommureOS unification sunsetting the Memora brand. Would show Memora failed to survive as a distinct product post-acquisition.
Epic or Salesforce Health Cloud ships native patient-engagement AI triage features. Would confirm incumbent EHR platforms are commoditizing Memora's core function.
Named Memora hospital customers publicly switch to Luma Health, Artera, or Innovaccer. Would show direct customer defection to peer patient-engagement vendors.
Key numbers
  • Acquired by Commure, Dec 20, 2024 (2024-12-20)
  • Raised roughly $80-90M total across 11 rounds (2023-04-18)
  • Commure raised $70M at $7B valuation (2026-05-19)
Named risks
  • Memora brand and product may be fully absorbed into CommureOS, ending independent identity. Severity: high
  • Reputational overhang from Axios 'fire sale' report of March 6 2025 inviting further scrutiny. Severity: medium
  • Core SMS triage product category being commoditized by generalized LLM and agentic AI. Severity: high
  • General Catalyst held stakes in both Memora pre sale and acquirer Commure, a conflict of interest. Severity: medium
  • Founder departure (Manav Sevak, April 2026) signals discontinuity from original vision. Severity: medium
Rivals, as read in July 2026
RivalDirectionEvidence
Epicgaining onEpic can natively bundle same patient messaging workflow as Memora, per analysis dated 2026-06-14
Salesforce Health Cloudgaining onBundled EHR/CRM patient engagement competes directly for same budget line, 2026-06-14
Luma HealthcontestingVendor claims Spark AI leads mid-market scheduling and FAQ deflection, per 2026-06-23 roundup
InnovaccercontestingBroader care coordination platform competing with Commure's $7B valued suite as of 2026-05-19
Commure (parent, internal)losing toMemora tools being absorbed into CommureOS integration engine per Dec 20 2024 press release
Questions people ask
Is Memora Health still an independent company?
No. Memora Health was acquired by Commure on December 20, 2024, per Commure's press release. Axios later called it a 'surprise fire sale' on March 6, 2025, reporting investors and employees believed the company was thriving before the deal.
Was Memora Health profitable before it was acquired?
No audited revenue figures were ever disclosed. Axios reported on March 6, 2025 that Memora's actual commercial traction appeared weaker than externally portrayed, contributing to what sources called a low-price 'fire sale' to Commure in December 2024.
Who owns Memora Health now?
Commure owns Memora Health, having acquired it December 20, 2024. Commure itself raised $70M at a $7B post-money valuation on May 19, 2026, led by General Catalyst with Sequoia Capital, Morgan Stanley, and Kirkland & Ellis participating.
Could AI replace Memora Health's product?
Memora's core SMS-based patient triage and FAQ deflection was itself an early AI use case, and is now being commoditized by generalized LLM/agentic AI. Its acquirer Commure already automates over 85% of certain administrative workflows without human intervention as of May 19, 2026.
Is Epic a bigger threat to Memora Health than other startups?
Yes. Epic and Salesforce Health Cloud can natively bundle the same patient-messaging workflow Memora built, per a June 14, 2026 industry analysis, meaning Memora's EHR integrations were never a moat against the EHR vendor itself.
Did Memora Health's founder leave after the acquisition?
Yes. Co-founder and former CEO Manav Sevak departed and launched a new venture, Novitas Holdings, in April 2026, roughly 16 months after Commure acquired Memora Health on December 20, 2024.
Timeline
  • 2026-06-25Commure named 'Overall NLP Company of the Year' in 2026 AI Breakthrough Awards
  • 2026-05-19Commure raises $70M at $7B post-money valuation led by General Catalyst
  • 2026-04Former Memora CEO Manav Sevak launches new venture, Novitas Holdings
  • 2025-03-06Axios reports Memora Commure deal as a 'surprise fire sale'
  • 2024-12-23FierceHealthcare reports Edward-Elmhurst Health no longer a Memora customer
  • 2024-12-20Commure acquires Memora Health, terms undisclosed
  • 2024Commure acquires Augmedix for $139M
  • 2023-06-27Memorial Hermann makes strategic investment; Memora AI answers over 30% of post op patient questions
  • 2023-04-18Memora announces $30M Series D led by General Catalyst
  • 2022-02-15Memora raises $40M Series C round
Revision history
22 July 2026
First assessed. Little protection left. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources